CCR-13674-05904
5 vaccinations
3 coded responses
42 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 379 / TN
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal discomfort, Oropharyngeal pain — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Sore throat/throat discomfortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Survey response — day 21, dose 1MedDRA: COVID-19 — Feeling: Fair · Be unable to workFree text: COVID-19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-08
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Survey response — day 28, dose 1MedDRA: Anosmia, COVID-19, Headache, Hypogeusia, Oversensing, Photophobia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Had covid, lost sense of smell, reduced taste, headache, light and noise sensitivity. Presume related to disease/infection not vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activitiesno matching call case
- 2021-01-15
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-28
- 2021-04-16
- 2021-07-16
-
2021-09-22
Dose 3 — Pfizer-BioNTech
- 2022-01-15
-
2022-04-18
Dose 4 — Pfizer-BioNTech
-
2022-04-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-23
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-07-20
-
2022-10-07
Dose 5 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-06
- 2022-11-11
- 2022-11-18
- 2023-01-06
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-22 | Pfizer-BioNTech | No |
| 4 | 2022-04-18 | Pfizer-BioNTech | No |
| 5 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
1 check-in flagged for a call with no call center case on record
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat/throat discomfort
Release 1 — day 21, dose 1
Symptoms: COVID-19
Release 2 — day 28, dose 1
Symptoms: Had covid, lost sense of smell, reduced taste, headache, light and noise sensitivity. Presume related to disease/infection not vaccination
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypogeusia | ✓ | ✓ | ✓ |
| SD | Oversensing | ✓ | ✓ | ✓ |
| SD | Photophobia | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal discomfort | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release